{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T14:10:45Z","timestamp":1786803045497,"version":"build-2736575974"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1007\/s00115-005-2019-1","type":"journal-article","created":{"date-parts":[[2005,12,8]],"date-time":"2005-12-08T16:33:03Z","timestamp":1134059583000},"page":"430-438","source":"Crossref","is-referenced-by-count":64,"title":["Plasmaaustausch bei steroidresistenten Multiple-Sklerose-Sch\u00fcben","Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses"],"prefix":"10.1007","volume":"77","author":[{"given":"S.","family":"Schilling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A.","family":"Linker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. B.","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Koziolek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"B\u00e4hr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. A.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"G\u00e4rtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Br\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"2019_CR1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/jnnp.50.5.511","volume":"50","author":"Milligan","year":"1987","unstructured":"Milligan NM, Newcombe R, Compston DA (1987) A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. clinical effects. J Neurol Neurosurg Psychiatry 50:511\u2013516","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2019_CR2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00415-004-1511-z","volume":"251","author":"Rieckmann","year":"2004","unstructured":"Rieckmann P, Toyka KV, Bassetti C et al. (2004) Escalating immunotherapy of multiple sclerosis\u2014new aspects and practical application. J Neurol 251:1329\u20131339","journal-title":"J Neurol"},{"key":"2019_CR3","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q","volume":"46","author":"Weinshenker","year":"1999","unstructured":"Weinshenker BG, O\u2019Brien PC, Petterson TM et al. (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46:878\u2013886","journal-title":"Ann Neurol"},{"key":"2019_CR4","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/01.WNL.0000138437.99046.6B","volume":"63","author":"Ruprecht","year":"2004","unstructured":"Ruprecht K, Klinker E, Dintelmann T et al. (2004) Plasma exchange for severe optic neuritis: treatment of 10 patients. Neurology 63:1081\u20131083","journal-title":"Neurology"},{"key":"2019_CR5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)67102-4","volume":"366","author":"Keegan","year":"2005","unstructured":"Keegan M, Konig F, McClelland R et al. (2005) Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 366:579\u2013582","journal-title":"Lancet"},{"key":"2019_CR6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"Lucchinetti","year":"2000","unstructured":"Lucchinetti C, Bruck W, Parisi J et al. (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707\u2013717","journal-title":"Ann Neurol"},{"key":"2019_CR7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1212\/WNL.58.1.143","volume":"58","author":"Keegan","year":"2002","unstructured":"Keegan M, Pineda AA, McClelland RL et al. (2002) Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 58:143\u2013146","journal-title":"Neurology"},{"key":"2019_CR8","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"Lucchinetti","year":"2002","unstructured":"Lucchinetti CF, Mandler RN, McGavern D et al. (2002) A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica. Brain 125:1450\u20131461","journal-title":"Brain"},{"key":"2019_CR9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0022-510X(97)00292-X","volume":"153","author":"Stangel","year":"1998","unstructured":"Stangel M, Hartung HP, Marx P et al. (1998) Intravenous immunoglobulin treatment of neurological autoimmune diseases. J Neurol Sci 153:203\u2013214","journal-title":"J Neurol Sci"},{"key":"2019_CR10","first-page":"173","volume":"7","author":"Bruck","year":"2001","unstructured":"Bruck W, Neubert K, Berger T et al. (2001) Clinical, radiological, immunological and pathological findings in inflammatory CNS demyelination\u2014possible markers for an antibody-mediated process. Mult Scler 7:173\u2013177","journal-title":"Mult Scler"},{"key":"2019_CR11","unstructured":"Mann H (2003) Apherese-Standard der Deutschen Arbeitsgemeinschaft f\u00fcr Klinische Nephrologie e.V."}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-005-2019-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-005-2019-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-005-2019-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T05:00:48Z","timestamp":1558587648000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-005-2019-1"}},"subtitle":["Klinische Erfahrungen an 16 Patienten","Clinical experience with 16 patients"],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["2019"],"URL":"https:\/\/doi.org\/10.1007\/s00115-005-2019-1","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}